Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{165810,
        author = {Rohit Shivcharan Patil and Swati Samadhan Patil and Kaveri Pradiprao Borse and Dishant Sunil Chaudhari and Mayuri Arun  Chaudhari and Komal Yuvraj  Chaudhari and Pratiksha Bhaiyyasaheb Patil},
        title = {Casting Light on Potential: A Thorough Examination of the Effectiveness, Challenges, and Future of Generic Medicines},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {1},
        pages = {1750-1758},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=165810},
        abstract = {Generic drugs, mirroring brand-name counterparts in composition and efficacy, offer substantial cost savings by circumventing expenses associated with research, development, and marketing. In India, despite economic advantages, challenges persist due to limited awareness of regulatory standards. However, initiatives promoting generic substitution are gaining traction among healthcare providers. Globally, the introduction of generics has revolutionized healthcare accessibility, especially benefiting marginalized populations. Governments advocate for generic use, emphasizing comparable clinical benefits to brand-name drugs at reduced costs, enabled by streamlined regulatory pathways prioritizing bioequivalence.},
        keywords = {ANDA, Brand drugs, Drug approval, FDA, Generic drugs, NDA.},
        month = {June},
        }